Walgreens Shows Delaware The Best Way To Lower Pharma Costs?

Update: Joint Meeting set for Tuesday to discuss Walgreens decision. Please let your reps know how you feel. We need to address Brand Name Drug advocacy in Delaware.
House Committee: Health & Human Development Chair: Michael A. Barbieri [S. Quinton Johnson, Donald A. Blakey, Gerald L. Brady, Earl G. Jaques, Thomas H. Kovach, John A. Kowalko, Nick T. Manolakos, Joseph E. Miro, William A. Oberle, Teresa Schooley, Darryl M. Scott, Robert E. Walls]
Senate Committee: Health & Social Services Chair: Margaret Rose Henry [Patricia M. Blevins, Bethany A. Hall-Long, Harris B. McDowell, Karen E. Peterson, Liane M. Sorenson]
Room:House Majority Hearing Room Date/Time: 06/09/2009 12:30:00 PM
~~~~~
Steve Newton has a "Best of Delaware Blogging' in the queue this morning. He finds the crux of Walgreen's argument compelling and concludes (among other things) ~

A 5% improvement in our generic fill rate for Medicaid, bringing Delaware up to 54%--or roughly the national average--would save the First State $6 million, and render the issue of cutting the reimbursement rate for brand names moot by simply not allowing their use as often.